Brown Advisory’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
16,979
+17
| +0.1% | +$1.11K | ﹤0.01% | 786 |
|
|
2025
Q1 | $1.14M | Hold |
16,962
| – | – | ﹤0.01% | 745 |
|
|
2024
Q4 | $938K | Hold |
16,962
| – | – | ﹤0.01% | 818 |
|
|
2024
Q3 | $1.01M | Hold |
16,962
| – | – | ﹤0.01% | 785 |
|
|
2024
Q2 | $1.08M | Sell |
16,962
-1,490
| -8% | -$94.9K | ﹤0.01% | 754 |
|
|
2024
Q1 | $1.28M | Hold |
18,452
| – | – | ﹤0.01% | 723 |
|
|
2023
Q4 | $1.02M | Hold |
18,452
| – | – | ﹤0.01% | 760 |
|
|
2023
Q3 | $1.07M | Sell |
18,452
-1,600
| -8% | -$92.9K | ﹤0.01% | 732 |
|
|
2023
Q2 | $1.08M | Sell |
20,052
-1,700
| -8% | -$91.5K | ﹤0.01% | 735 |
|
|
2023
Q1 | $864K | Hold |
21,752
| – | – | ﹤0.01% | 788 |
|
|
2022
Q4 | $875K | Hold |
21,752
| – | – | ﹤0.01% | 782 |
|
|
2022
Q3 | $699K | Hold |
21,752
| – | – | ﹤0.01% | 784 |
|
|
2022
Q2 | $645K | Buy |
21,752
+4,118
| +23% | +$122K | ﹤0.01% | 790 |
|
|
2022
Q1 | $496K | Buy |
17,634
+3,333
| +23% | +$93.7K | ﹤0.01% | 862 |
|
|
2021
Q4 | $659K | Hold |
14,301
| – | – | ﹤0.01% | 813 |
|
|
2021
Q3 | $469K | Hold |
14,301
| – | – | ﹤0.01% | 839 |
|
|
2021
Q2 | $501K | Hold |
14,301
| – | – | ﹤0.01% | 842 |
|
|
2021
Q1 | $517K | Sell |
14,301
-180
| -1% | -$6.51K | ﹤0.01% | 838 |
|
|
2020
Q4 | $420K | Buy |
14,481
+180
| +1% | +$5.22K | ﹤0.01% | 814 |
|
|
2020
Q3 | $403K | Buy |
14,301
+1,991
| +16% | +$56.1K | ﹤0.01% | 775 |
|
|
2020
Q2 | $398K | Hold |
12,310
| – | – | ﹤0.01% | 767 |
|
|
2020
Q1 | $502K | Hold |
12,310
| – | – | ﹤0.01% | 691 |
|
|
2019
Q4 | $759K | Hold |
12,310
| – | – | ﹤0.01% | 690 |
|
|
2019
Q3 | $897K | Buy |
12,310
+1,200
| +11% | +$87.4K | ﹤0.01% | 639 |
|
|
2019
Q2 | $913K | Hold |
11,110
| – | – | ﹤0.01% | 649 |
|
|
2019
Q1 | $784K | Buy |
+11,110
| New | +$784K | ﹤0.01% | 864 |
|